| 72.91 BATS BZX Real-Time Price As of 9:48am ET |  +0.52 / +0.71%Today’s Change | 62.66 Today|||52-Week Range 96.60 | -20.92% Year-to-Date |
| Previous close | 72.39 |
| Today’s open | 72.37 |
| Day’s range | 72.09 - 72.94 |
| Volume | 21,053 |
| Average volume (3 months) | 9,630,132 |
| Market cap | $107.1B |
| Earnings growth (last year) | +10.88% |
| Earnings growth (this year) | +12.47% |
| Earnings growth (next 5 years) | +6.00% |
| Revenue growth (last year) | +16.08% |
| P/E ratio | 25.8 |
| Price/Sales | 4.35 |
| Price/Book | -- |
| Today’s change | Today’s % change | |
|---|---|---|
| GSKGlaxoSmithKline | +0.29 | +0.70% |
| LLYEli Lilly and Co | -0.52 | -0.45% |
| SNYSanofi | -0.44 | -0.95% |
| NVONovo Nordisk | +0.45 | +0.85% |
| Next reporting date | October 28, 2019 |
| EPS forecast (this quarter) | $2.29 |
| Annual revenue (last year) | $32.8B |
| Annual profit (last year) | $5.7B |
| Net profit margin | 17.27% |
Sector Health Technology |
Industry Pharmaceuticals: Major |
Chairman & Chief Executive Officer Richard A. Gonzalez |
Vice Chairman & President Michael E. Severino |
Corporate headquarters North Chicago, Illinois |
